vs
Side-by-side financial comparison of Public Storage (PSA) and Zoetis (ZTS). Click either name above to swap in a different company.
Zoetis is the larger business by last-quarter revenue ($2.4B vs $1.2B, roughly 2.0× Public Storage). Public Storage runs the higher net margin — 41.7% vs 25.3%, a 16.4% gap on every dollar of revenue. On growth, Public Storage posted the faster year-over-year revenue change (3.3% vs 3.0%). Over the past eight quarters, Zoetis's revenue compounded faster (4.4% CAGR vs 2.5%).
Public Storage, headquartered in Glendale, California, is a real estate investment trust that invests in self storage. It is the largest brand of self-storage services in the US and owns approximately 9% of the self storage square footage in the U.S. As of December 31, 2024, the company operated 3,073 self-storage facilities containing an aggregate of 221 million net rentable square feet of space.
Zoetis Inc. (/zō-EH-tis/) is an American drug company, the world's largest producer of medicine and vaccinations for pets and livestock. The company was a subsidiary of Pfizer, the world's largest drug maker, but with Pfizer's spinoff of its 83% interest in the firm it is now a completely independent company. The company directly markets its products in approximately 45 countries, and sells them in more than 100 countries. Operations outside the United States accounted for 50% of the total re...
PSA vs ZTS — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $1.2B | $2.4B |
| Net Profit | $507.1M | $603.0M |
| Gross Margin | — | 70.2% |
| Operating Margin | 40.7% | 31.9% |
| Net Margin | 41.7% | 25.3% |
| Revenue YoY | 3.3% | 3.0% |
| Net Profit YoY | -17.5% | 3.8% |
| EPS (diluted) | $2.59 | $1.37 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.2B | $2.4B | ||
| Q3 25 | $1.2B | $2.4B | ||
| Q2 25 | $1.2B | $2.5B | ||
| Q1 25 | $1.2B | $2.2B | ||
| Q4 24 | $1.2B | $2.3B | ||
| Q3 24 | $1.2B | $2.4B | ||
| Q2 24 | $1.2B | $2.4B | ||
| Q1 24 | $1.2B | $2.2B |
| Q4 25 | $507.1M | $603.0M | ||
| Q3 25 | $511.1M | $721.0M | ||
| Q2 25 | $358.4M | $718.0M | ||
| Q1 25 | $407.8M | $631.0M | ||
| Q4 24 | $614.6M | $581.0M | ||
| Q3 24 | $430.3M | $682.0M | ||
| Q2 24 | $518.1M | $624.0M | ||
| Q1 24 | $508.9M | $599.0M |
| Q4 25 | — | 70.2% | ||
| Q3 25 | — | 71.5% | ||
| Q2 25 | — | 73.6% | ||
| Q1 25 | — | 72.0% | ||
| Q4 24 | — | 69.5% | ||
| Q3 24 | — | 70.6% | ||
| Q2 24 | — | 71.7% | ||
| Q1 24 | — | 70.6% |
| Q4 25 | 40.7% | 31.9% | ||
| Q3 25 | 42.3% | 37.0% | ||
| Q2 25 | 30.4% | 36.7% | ||
| Q1 25 | 34.8% | 36.5% | ||
| Q4 24 | 52.4% | 31.6% | ||
| Q3 24 | 36.7% | 36.6% | ||
| Q2 24 | 44.6% | 33.0% | ||
| Q1 24 | 44.3% | 34.1% |
| Q4 25 | 41.7% | 25.3% | ||
| Q3 25 | 41.8% | 30.0% | ||
| Q2 25 | 29.8% | 29.2% | ||
| Q1 25 | 34.5% | 28.4% | ||
| Q4 24 | 52.2% | 25.1% | ||
| Q3 24 | 36.2% | 28.6% | ||
| Q2 24 | 44.2% | 26.4% | ||
| Q1 24 | 44.0% | 27.4% |
| Q4 25 | $2.59 | $1.37 | ||
| Q3 25 | $2.62 | $1.63 | ||
| Q2 25 | $1.76 | $1.61 | ||
| Q1 25 | $2.04 | $1.41 | ||
| Q4 24 | $3.22 | $1.29 | ||
| Q3 24 | $2.16 | $1.50 | ||
| Q2 24 | $2.66 | $1.37 | ||
| Q1 24 | $2.60 | $1.31 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $318.1M | — |
| Total DebtLower is stronger | $10.3B | — |
| Stockholders' EquityBook value | $9.2B | $3.3B |
| Total Assets | $20.2B | $15.5B |
| Debt / EquityLower = less leverage | 1.11× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $318.1M | — | ||
| Q3 25 | $296.5M | $2.1B | ||
| Q2 25 | $1.1B | $1.4B | ||
| Q1 25 | $287.2M | $1.7B | ||
| Q4 24 | $447.4M | $2.0B | ||
| Q3 24 | $599.0M | $1.7B | ||
| Q2 24 | $542.3M | $1.6B | ||
| Q1 24 | $271.6M | $2.0B |
| Q4 25 | $10.3B | — | ||
| Q3 25 | $10.0B | — | ||
| Q2 25 | $10.4B | — | ||
| Q1 25 | $9.4B | — | ||
| Q4 24 | $9.4B | — | ||
| Q3 24 | $9.5B | — | ||
| Q2 24 | $9.4B | — | ||
| Q1 24 | $9.1B | — |
| Q4 25 | $9.2B | $3.3B | ||
| Q3 25 | $9.3B | $5.4B | ||
| Q2 25 | $9.4B | $5.0B | ||
| Q1 25 | $9.6B | $4.7B | ||
| Q4 24 | $9.7B | $4.8B | ||
| Q3 24 | $9.6B | $5.2B | ||
| Q2 24 | $9.7B | $5.0B | ||
| Q1 24 | $9.9B | $5.1B |
| Q4 25 | $20.2B | $15.5B | ||
| Q3 25 | $20.1B | $15.2B | ||
| Q2 25 | $20.5B | $14.5B | ||
| Q1 25 | $19.6B | $14.1B | ||
| Q4 24 | $19.8B | $14.2B | ||
| Q3 24 | $19.8B | $14.4B | ||
| Q2 24 | $19.8B | $14.2B | ||
| Q1 24 | $19.6B | $14.3B |
| Q4 25 | 1.11× | — | ||
| Q3 25 | 1.08× | — | ||
| Q2 25 | 1.11× | — | ||
| Q1 25 | 0.99× | — | ||
| Q4 24 | 0.96× | — | ||
| Q3 24 | 0.99× | — | ||
| Q2 24 | 0.97× | — | ||
| Q1 24 | 0.91× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $733.6M | $893.0M |
| Free Cash FlowOCF − Capex | — | $732.0M |
| FCF MarginFCF / Revenue | — | 30.7% |
| Capex IntensityCapex / Revenue | — | 6.7% |
| Cash ConversionOCF / Net Profit | 1.45× | 1.48× |
| TTM Free Cash FlowTrailing 4 quarters | — | $2.3B |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $733.6M | $893.0M | ||
| Q3 25 | $875.1M | $938.0M | ||
| Q2 25 | $872.7M | $486.0M | ||
| Q1 25 | $705.1M | $587.0M | ||
| Q4 24 | $768.6M | $905.0M | ||
| Q3 24 | $798.8M | $951.0M | ||
| Q2 24 | $895.3M | $502.0M | ||
| Q1 24 | $665.6M | $595.0M |
| Q4 25 | — | $732.0M | ||
| Q3 25 | — | $805.0M | ||
| Q2 25 | — | $308.0M | ||
| Q1 25 | — | $438.0M | ||
| Q4 24 | — | $689.0M | ||
| Q3 24 | — | $784.0M | ||
| Q2 24 | — | $370.0M | ||
| Q1 24 | — | $455.0M |
| Q4 25 | — | 30.7% | ||
| Q3 25 | — | 33.5% | ||
| Q2 25 | — | 12.5% | ||
| Q1 25 | — | 19.7% | ||
| Q4 24 | — | 29.7% | ||
| Q3 24 | — | 32.8% | ||
| Q2 24 | — | 15.7% | ||
| Q1 24 | — | 20.8% |
| Q4 25 | — | 6.7% | ||
| Q3 25 | — | 5.5% | ||
| Q2 25 | — | 7.2% | ||
| Q1 25 | — | 6.7% | ||
| Q4 24 | — | 9.3% | ||
| Q3 24 | — | 7.0% | ||
| Q2 24 | — | 5.6% | ||
| Q1 24 | — | 6.4% |
| Q4 25 | 1.45× | 1.48× | ||
| Q3 25 | 1.71× | 1.30× | ||
| Q2 25 | 2.43× | 0.68× | ||
| Q1 25 | 1.73× | 0.93× | ||
| Q4 24 | 1.25× | 1.56× | ||
| Q3 24 | 1.86× | 1.39× | ||
| Q2 24 | 1.73× | 0.80× | ||
| Q1 24 | 1.31× | 0.99× |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
PSA
| Self Storage Operations | $1.1B | 93% |
| Ancillary Operations | $86.9M | 7% |
ZTS
| Other | $1.3B | 56% |
| Livestock | $234.0M | 10% |
| Pain Sedation | $209.0M | 9% |
| Other Pharmaceuticals | $188.0M | 8% |
| Swine | $125.0M | 5% |
| Poultry | $117.0M | 5% |
| Fish | $81.0M | 3% |
| Other Non Pharmaceuticals | $70.0M | 3% |
| Manufactured Product Other | $18.0M | 1% |
| Medicated Feed Additives | $12.0M | 1% |
